BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 33536430)

  • 1. Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia.
    Gasca-Salas C; Fernández-Rodríguez B; Pineda-Pardo JA; Rodríguez-Rojas R; Obeso I; Hernández-Fernández F; Del Álamo M; Mata D; Guida P; Ordás-Bandera C; Montero-Roblas JI; Martínez-Fernández R; Foffani G; Rachmilevitch I; Obeso JA
    Nat Commun; 2021 Feb; 12(1):779. PubMed ID: 33536430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatal Blood-Brain Barrier Opening in Parkinson's Disease Dementia: A Pilot Exploratory Study.
    Pineda-Pardo JA; Gasca-Salas C; Fernández-Rodríguez B; Rodríguez-Rojas R; Del Álamo M; Obeso I; Hernández-Fernández F; Trompeta C; Martínez-Fernández R; Matarazzo M; Mata-Marín D; Guida P; Duque A; Albillo D; Plaza de Las Heras I; Montero JI; Foffani G; Toltsis G; Rachmilevitch I; Blesa J; Obeso JA
    Mov Disord; 2022 Oct; 37(10):2057-2065. PubMed ID: 35765711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease: long-term safety, imaging, and cognitive outcomes.
    Rezai AR; Ranjan M; Haut MW; Carpenter J; D'Haese PF; Mehta RI; Najib U; Wang P; Claassen DO; Chazen JL; Krishna V; Deib G; Zibly Z; Hodder SL; Wilhelmsen KC; Finomore V; Konrad PE; Kaplitt M;
    J Neurosurg; 2023 Jul; 139(1):275-283. PubMed ID: 36334289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-Brain Barrier Opening with MRI-guided Focused Ultrasound Elicits Meningeal Venous Permeability in Humans with Early Alzheimer Disease.
    Mehta RI; Carpenter JS; Mehta RI; Haut MW; Ranjan M; Najib U; Lockman P; Wang P; D'haese PF; Rezai AR
    Radiology; 2021 Mar; 298(3):654-662. PubMed ID: 33399511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound.
    Abrahao A; Meng Y; Llinas M; Huang Y; Hamani C; Mainprize T; Aubert I; Heyn C; Black SE; Hynynen K; Lipsman N; Zinman L
    Nat Commun; 2019 Sep; 10(1):4373. PubMed ID: 31558719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study.
    Mainprize T; Lipsman N; Huang Y; Meng Y; Bethune A; Ironside S; Heyn C; Alkins R; Trudeau M; Sahgal A; Perry J; Hynynen K
    Sci Rep; 2019 Jan; 9(1):321. PubMed ID: 30674905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paramagnetic perfluorocarbon-filled albumin-(Gd-DTPA) microbubbles for the induction of focused-ultrasound-induced blood-brain barrier opening and concurrent MR and ultrasound imaging.
    Liao AH; Liu HL; Su CH; Hua MY; Yang HW; Weng YT; Hsu PH; Huang SM; Wu SY; Wang HE; Yen TC; Li PC
    Phys Med Biol; 2012 May; 57(9):2787-802. PubMed ID: 22510713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy.
    Lamsam L; Johnson E; Connolly ID; Wintermark M; Hayden Gephart M
    Neurosurg Focus; 2018 Feb; 44(2):E10. PubMed ID: 29385922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery.
    Alli S; Figueiredo CA; Golbourn B; Sabha N; Wu MY; Bondoc A; Luck A; Coluccia D; Maslink C; Smith C; Wurdak H; Hynynen K; O'Reilly M; Rutka JT
    J Control Release; 2018 Jul; 281():29-41. PubMed ID: 29753957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer's disease with an implantable ultrasound device.
    Epelbaum S; Burgos N; Canney M; Matthews D; Houot M; Santin MD; Desseaux C; Bouchoux G; Stroer S; Martin C; Habert MO; Levy M; Bah A; Martin K; Delatour B; Riche M; Dubois B; Belin L; Carpentier A
    Alzheimers Res Ther; 2022 Mar; 14(1):40. PubMed ID: 35260178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current applications for magnetic resonance-guided focused ultrasound in the treatment of Parkinson's disease.
    Lu H; Wang X; Lou X
    Chin Med J (Engl); 2023 Apr; 136(7):780-787. PubMed ID: 36914938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive frontal focused ultrasound mediated blood-brain barrier opening for the treatment of Alzheimer's disease: a proof-of-concept study.
    Park SH; Baik K; Jeon S; Chang WS; Ye BS; Chang JW
    Transl Neurodegener; 2021 Nov; 10(1):44. PubMed ID: 34740367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound.
    Meng Y; Goubran M; Rabin JS; McSweeney M; Ottoy J; Pople CB; Huang Y; Storace A; Ozzoude M; Bethune A; Lam B; Swardfager W; Heyn C; Abrahao A; Davidson B; Hamani C; Aubert I; Zetterberg H; Ashton NJ; Karikari TK; Blennow K; Black SE; Hynynen K; Lipsman N
    Brain; 2023 Mar; 146(3):865-872. PubMed ID: 36694943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound.
    Rezai AR; Ranjan M; D'Haese PF; Haut MW; Carpenter J; Najib U; Mehta RI; Chazen JL; Zibly Z; Yates JR; Hodder SL; Kaplitt M
    Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9180-9182. PubMed ID: 32284421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safe long-term repeated disruption of the blood-brain barrier using an implantable ultrasound device: a multiparametric study in a primate model.
    Horodyckid C; Canney M; Vignot A; Boisgard R; Drier A; Huberfeld G; François C; Prigent A; Santin MD; Adam C; Willer JC; Lafon C; Chapelon JY; Carpentier A
    J Neurosurg; 2017 Apr; 126(4):1351-1361. PubMed ID: 27285538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound.
    Lipsman N; Meng Y; Bethune AJ; Huang Y; Lam B; Masellis M; Herrmann N; Heyn C; Aubert I; Boutet A; Smith GS; Hynynen K; Black SE
    Nat Commun; 2018 Jul; 9(1):2336. PubMed ID: 30046032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study.
    Palermo G; Tommasini L; Aghakhanyan G; Frosini D; Giuntini M; Tognoni G; Bonuccelli U; Volterrani D; Ceravolo R
    J Alzheimers Dis; 2019; 70(2):597-609. PubMed ID: 31256138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovative Applications of MR-Guided Focused Ultrasound for Neurological Disorders.
    Stavarache MA; Chazen JL; Kaplitt MG
    World Neurosurg; 2021 Jan; 145():581-589. PubMed ID: 33348524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative pressure and microbubble-size dependence study of focused ultrasound-induced blood-brain barrier opening reversibility in vivo using MRI.
    Samiotaki G; Vlachos F; Tung YS; Konofagou EE
    Magn Reson Med; 2012 Mar; 67(3):769-77. PubMed ID: 21858862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-Brain Barrier Closure Time After Controlled Ultrasound-Induced Opening Is Independent of Opening Volume.
    O'Reilly MA; Hough O; Hynynen K
    J Ultrasound Med; 2017 Mar; 36(3):475-483. PubMed ID: 28108988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.